default author photo

Alexandra Leary

Université Paris XI Sud - Gustave Roussy Cancer Campus

114 Rue Edouard Vaillant

94800 Villejuif

France

SCHOLARLY PAPERS

4

DOWNLOADS

310

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

Interpretable Deep Learning Predicts the Molecular Endometrial Cancer Classification from H&E Images: A Combined Analysis of the Portec Randomized Clinical Trials

Number of pages: 25 Posted: 24 Jun 2022
Leiden University, Medical Center (LUMC), Department of Pathology, University Hospital Zurich - Department of Pathology and Molecular Pathology, Leiden University, Medical Center (LUMC), Department of Pathology, Leiden University - Department of Vascular and Molecular Imaging, Leiden University, Medical Center (LUMC), Department of Pathology, Medisch Spectrum Twente - Department of Radiation Oncology, Laboratorium Pathologie Oost-Nederland (LabPON) - Department of Pathology, Laboratorium Pathologie Oost-Nederland (LabPON) - Department of Pathology, University Medical Center Utrecht - Department of Radiation Oncology, Maastricht University - Department of Radiation Oncology (MAASTRO), Erasmus University Medical Center Rotterdam - Department of Radiation Oncology, Radiotherapiegroep - Department of Radiation Oncology, Leiden University - Department of Radiation Oncology, Government of the United Kingdom - Department of Clinical Oncology, Barts Health NHS Trust, Department of Cellular Pathology, Peter MacCallum Cancer Centre - Department of Medical Oncology, University of Toronto - Department of Medical Oncology and Hematology, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Groningen - Department of Obstetrics and Gynecology, Leiden University, Medical Center (LUMC), Department of Pathology, Leiden University - Department of Radiation Oncology, Leiden University - Department of Radiation Oncology, University Hospital Zurich - Department of Pathology and Molecular Pathology and Leiden University, Medical Center (LUMC), Department of Pathology
Downloads 130 (558,171)
Citation 1

Abstract:

Loading...

deep learning, Endometrial Cancer, Molecular classification, Morphological features, Prognostic refinement, POLEmut EC, MMRd EC, NSMP EC, p53abn EC, whole slide images, Histopathology images.

2.

Avelumab Alone or in Combination with Chemotherapy vs Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): A Randomised, Open-Label, Phase 3 Study

Number of pages: 52 Posted: 28 Oct 2020
ARCAGY-GINECO, Saitama Medical University International Medical Center (SIMC), University College London - UCL Cancer Institute, University of Toronto - Princess Margaret Cancer Centre, University College London - UCL Cancer Institute, University of Claude Bernard Lyon 1 - Medical Oncology Department, Cabrini Hospital - Department of Medical Oncology, Ospedale San Giovanni - Oncology Institute of Southern Switzerland (IOSI), National Cancer Center Hospital - Department of Breast and Medical Oncology, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Université Paris XI Sud - Gustave Roussy Cancer Campus, BC Cancer, University of Ulsan - Department of Oncology, Poznan University of Medical Sciences - Department of Oncology, National Cancer Center - Center for Uterine CancerNational Cancer Center, Korea - Center for Gynecologic Cancer, Willamette Valley Cancer Institute and Research Center, Pfizer Oncology, Pfizer Oncology, Pfizer, Inc. - Pfizer Global Biometrics and Data Management, Pfizer Oncology and University of Arizona - College of Medicine, Arizona Oncology (US Oncology Network)
Downloads 101 (684,672)

Abstract:

Loading...

ovarian cancer, Avelumab, PD-L1, Phase 3, immune checkpoint inhibitor

3.

Early Clinical and Molecular Biomarkers in Advanced Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy: Chiva Phase Ii Gineco Trial

Number of pages: 22 Posted: 07 Oct 2024
University of Paris-Saclay - Institut Gustave Roussy, University of Paris-Saclay - Institut Gustave Roussy, Université Lyon 1 - Faculty of Medicine Lyon-Sud, affiliation not provided to SSRN, University of Claude Bernard Lyon 1 - Medical Oncology Department, affiliation not provided to SSRN, University of Lille II - Centre Oscar Lambret, Université de Caen, Institut Claudius Regaud, affiliation not provided to SSRN, Université Lyon 1 - Faculty of Medicine Lyon-Sud, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Bordeaux - Institut Bergonié, University of Limoges - CHU Limoges, affiliation not provided to SSRN, Institut Mutualiste Montsouris, Western Cancer Institute, ARCAGY-GINECO, Gustave Roussy, Gustave Roussy, affiliation not provided to SSRN, Gustave Roussy and Université Paris XI Sud - Gustave Roussy Cancer Campus
Downloads 46 (1,109,210)

Abstract:

Loading...

Ovarian cancer, neoadjuvant chemotherapy, biomarkers, homologous recombination deficiency, TILS

4.

Loss-of-Heterozygosity as a Biomarker of Genomic Instability in Endometrial Cancer

Number of pages: 13 Posted: 05 Sep 2024
University of Paris-Saclay - Institut Gustave Roussy, University of Paris-Saclay - Institut Gustave Roussy, University of Paris-Saclay - Institut Gustave Roussy, University of Paris-Saclay - Institut Gustave Roussy, University of Paris-Saclay - Institut Gustave Roussy, University of Paris-Saclay - Institut Gustave Roussy, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Université Paris XI Sud - Gustave Roussy Cancer Campus and National University Health System (NUHS) - National University Cancer Institute
Downloads 33 (1,277,121)

Abstract:

Loading...

Endometrial cancer, genomic instability, homologous recombination deficiency, predictive biomarkers, personalized treatment